Lung cancer is the most common and serious types of cancer. Early diagnosis, lung cancer screening and treatment can save lives. Find more information about lung cancer, visit ➡️https://t.co/t9avUNCFE7#LungCancerAwarenessMonthpic.twitter.com/0VN66GJgb2 — NHS North West (@NHSNW)Nove...
Cancer cell membrane-modified bio-nanocarriers (CCMNs) are widely researched for oncological targeting of various payloads [102,103]. CCMNs confer unique attributes to the nanoparticles like homotypic targetability, unique binding ability, and selective cell uptake to primary and metastatic tumor nodule...
Cancer is a major public health problem worldwide [1,2,3]. Lung cancer, one of the most prevalent tumors with the highest mortality rate, originates in the trachea, bronchus and lungs, and its prevalence threatens human health [4,5]. Systemic lung cancer therapy includes surgery, radiation...
shown by different colors. Compared to non-carriers, Q4X carriers had a significantly increased lung cancer risk with ORs being 2.59 in the discovery (P = 1.15 × 10−18,n = 27966) and 1.69 in the replication datasets (P = 0.03,n = 10248). Stratified analysis ...
Insufficient chemotherapy response and rapid disease progression remain concerns for small-cell lung cancer (SCLC). Oncologists rely on serial CT scanning to guide treatment decisions, but this cannot assess in vivo target engagement of therapeutic agent
This review provides an overview of the conventional methods currently used for lung cancer screening, classification, diagnosis, and prognosis, providing updates on research and developments in biosensor technology for the detection of lung cancer biomarkers in biological samples. Finally, it comments on...
Lung cancer screening with low-dose CT: Implementation amid changing public policy at one health care system. Am. Soc. Clin. Oncol. Educ. Book 2016, 35, e468–e475. [CrossRef] [PubMed] 7. Eberth, J.M.; Sercy, E. Implementation of lung cancer screening in the United States: Changing...
Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy’s and St Thomas’ NHS Foundation Trust/National Heart and Lung Institute, Imperial College London, Sydney Street, London SW3 6NP, UK * Author to whom correspondence should be addressed. ...
The possibility of patient-specific iPSCs offers great hope for generating genetically matched patient-specific lung progenitor cells, with the opportunity for patient specific regenerative cell therapy and drug screening as well as in vitro modelling of human diseases [87]. ESCs, in in vitro ...
As most cases of lung adenocarcinoma are found at advanced stages, even with regular radiographic screening, improved detection of early lung adenocarcinoma at a curable stage would decrease lung cancer-related deaths and avoid costly treatments. Over the past several decades, novel strategies based ...